Skip to main content
Date :

Join us to learn collaboration opportunities with 6 leading Japanese pharmaceutical companies!

Department for Business and Trade (DBT) Japan are delighted to host the 3rd webinar inviting speakers from pre-clinical stage R&D / Business Development of Japan’s leading pharmaceutical companies: Astellas Pharma Inc, Daiichi Sankyo Co Ltd, Mitsubishi Tanabe Pharma Corporation, Otsuka Pharmaceutical Co Ltd, Shionogi & Co Ltd and Sumitomo Pharma Co Ltd.   

This webinar is targeted for UK organisations in the Life Sciences industry and an ideal opportunity to learn research priorities and collaboration structures of the Japanese pharmaceutical companies.

DBT Japan Team will also assist 1:1 call requests from UK companies.  After you join the webinar, please send non-confidential information to DBT Japan at LS.Japan.trade@fco.gov.uk, indicating which companies you wish to have a meeting with, and how your technology fits their research priorities.  We will set up meetings with those agreed.

Date: Tuesday 4th July 2023

Time: 09:00 – 10:30 UK Time

Registration Deadline: 3rd July 2023

Programme:

9.00                 Opening Remarks / Housekeeping 

9:05-9:20        Astellas Pharma Inc

9:20-9:35        Daiichi Sankyo Co Ltd 

9:35-9:50        Mitsubishi Tanabe Pharma Corporation 

9:50-10:05      Otsuka Pharmaceutical Co Ltd 

10:05-10:20    Shionogi & Co Ltd

10:20-10:35    Sumitomo Pharma Co Ltd

10:35               Closing 

*Q&A Moderator: Dr Ivana Poparic, Head of Life Sciences Cluster Development, London & Partners

Venue and Location Information:
Platform: Zoom (pre-registration required – eligible companies with UK registered address will receive the Zoom link before the webinar)